Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines
By R. Asherson, R. Cervera, P. G. D. Groot, D. Erkan, M. Boffa, J. Piette, M. Khamashta, Y. Shoenfeld. Lupus, 2003
805 citations recorded by the source corpus.
Subfields: Hematology, Neurology, Rheumatology
View Paper: https://www.semanticscholar.org/paper/a63d66c3fa58f0e90f6613ffb83a38351db67a6d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- R. Cervera
- R. Serrano
- Y. Shoenfeld
- M. Tektonidou
- R. Derksen
- M. Zeher
- T. Tarr
- G. Pons-Estel
Citations in the corpus
- Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients (2009, background): “Patients were considered to have catastrophic APS if they presented with an acutely devastating APS with multiple (>3) organ involvement, mainly affecting small vessels supplying organs and presenting over a short period of time (”
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue (2019, neutral): “References [226–244]”